CELEX: 32014M7294
Language: en
Date: 2014-07-08 00:00:00
Title: Commission Decision of 08/07/2014 declaring a concentration to be compatible with the common market (Case No COMP/M.7294 - CARLYLE / HAIER GROUP / HAIER BIOMEDICAL AND LABORATORY PRODUCT) according to Council Regulation (EC) No 139/2004 (Only the English text is authentic)

|[pic]                             |EUROPEAN COMMISSION                                                                                      |
|                                  |                                                                                                         |
|                                  |                                                                                                         |
|                                  |                                                                                                         |
|                                  |                                                                                                         |

                                        Brussels, 8.7.2014
                                        C(2014) 4947 final

                                        |PUBLIC VERSION                                   |
|                                                 |
|SIMPLIFIED MERGER PROCEDURE                      |

                                        |                                                                   |To the notifying parties                                           |

Dear Madam(s) and/or Sir(s),

Subject:    Case M.7294 - CARLYLE/ HAIER GROUP/ HAIER BIOMEDICAL AND LABORATORY PRODUCT
         Commission decision pursuant to Article 6(1)(b) of Council Regulation (EC) No 139/2004[1]

   1. On 6 June 2014, the European Commission received notification of a proposed concentration pursuant to Article 4 of the Merger Regulation by
      which the Carlyle Group L.P. ('Carlyle', USA) and Haier Group Corporation ('Haier Group', China) intend to acquire within  the  meaning  of
      Art. 3 (1)(b) of the Merger Regulation joint control of the undertaking Haier Biomedical and Laboratory Products Co., Ltd. ('HBML', China),
      currently solely controlled by the Haier Group[2].

2.    The business activities of the undertakings concerned are:

      - for Carlyle: global alternative asset manager;

      - for Haier Group: multinational manufacturer and supplier of consumer electronics and home appliances;

      - for HBML: supplier of general laboratory equipment, in particular medical freezers, medical fridges/deep freezers and  biomedical  safety
      hoods.

3.    After examination of the notification, the European Commission has concluded that the notified operation falls  within  the  scope  of  the
    Merger Regulation and of paragraph 5(a) and 5(c) of the Commission Notice on a simplified procedure for treatment of  certain  concentrations
    under Council Regulation (EC) No 139/2004.[3]

4.    For the reasons set out in the Notice on a simplified procedure, the European Commission has decided not to oppose the  notified  operation
    and to declare it compatible with the internal market and with the EEA Agreement. This decision is adopted in application of Article  6(1)(b)
    of the Merger Regulation.

                                        For the Commission
                                        (Signed)
                                        Alexander ITALIANER
                                        Director-General

                                        -----------------------
[1]   OJ L 24, 29.1.2004, p. 1 ('the Merger Regulation'). With effect from 1 December 2009, the Treaty on the Functioning of the  European  Union
      ('TFEU') has introduced certain changes, such as the replacement of 'Community' by 'Union' and 'common market' by  'internal  market'.  The
      terminology of the TFEU will be used throughout this decision.
[2]   Publication in the Official Journal of the European Union No C 185, 17.6.2014, p. 46.

[3]   OJ C 366, 14.12.2013, p. 5.